ÍâÍøÁÔÆæ

Specialization include Pharmaceutics, Pharmaceutical Engineering and Technology, Drug Delivery, Nano-and Microparticulate Drug Delivery Systems, Nanotechnology, Nanoscience, Biomedical Engineering. Film Formulations, Stimuli responsive in situ gelling systems, Pharmaceutical Analysis, Cancer and anti-infective Drug Delivery.

Oluwadamilola Kolawole is a Senior Lecturer in Pharmacy at ÍâÍøÁÔÆæ School of Pharmacy, with specialisation in Pharmaceutical Sciences and Technology. Also, she is the Link Tutor and Leader of the MSci Pharmacy programme at Pharmaceutical Technical University, Tashkent, Uzbekistan. She is a member of the Royal Society of Chemistry and a recipient of various, educational, research and travel grants. She has over a decade experience in teaching, research administration, including scientific conference and organisation, academic staff training, and academic curriculum development/review. In addition, she has five years’ experience in the regulation of pharmaceutical processes and products.

She has research interests in generation of biocompatible, mucoadhesive materials for biomedical applications, and she applies chemistry, biology, physics and engineering to her research. She is experienced in the development of emulsified systems, hydrogels, stimuli responsive dosage forms, nanoparticles, microparticles, and pharmaceutical films for topical and transmucosal drug delivery – ocular, bladder, buccal, skin, transdermal, vaginal, rectal routes of drug administration, etc.

She has published numerous articles in peer-reviewed quality pharmaceutical and chemistry journals and is also a peer reviewer for various journal publishers (Elsevier, Taylor & Francis, ACS, and Dove Medical Press). She has delivered presentations (national and international) at symposia, universities and conferences). She has supervised numerous undergraduate and postgraduate students to completion.

Leicester Institute of Pharmaceutical Innovation for Integrated Care (LIPIIC)

Selected Publications

• Kolawole O. M., Okeke P. K. Formulation and evaluation of fluconazole containing boronated 4 arm polyethylene glycol, polyvinyl pyrrolidone, methyl cellulose-based films for the potential treatment of Vaginal Candidiasis. Journal of Drug Delivery Science and Technology 2025; 107: 106838.
• Kolawole O. M., Khutoryanskiy V. V. Potential bladder cancer therapeutic delivery systems: a recent update. Expert Opinion on Drug Delivery 2024 volume 21 issue 9, 1311-1329
• Kolawole O. M., Abu Ellela M. Recent Advances in modified chitosan-based drug delivery systems for transmucosal applications. Int J Biol Macromolecules 2024 volume 227, part 4 page 134531
• Ogedengbe O. T., Kolawole O. M. Formulation and evaluation of fluconazole emulgels for potential treatment of vaginal candidiasis. Heliyon 2024; 10: e28206
• Kolawole O. M. Agbelusi T., Patrojanasophon P. Synthesis and Evaluation of Boronated 4 arm polyethylene glycol for Application in Transmucosal Drug Delivery. Chemistry Select 2024; 9: e202304781 (1-10)
• Kolawole O. M., Ifeanafor A. R. Ifade W., Akinleye M., Silva B. O., Akinniyi A. Formulation and evaluation of paclitaxel loaded boronated chitosan alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery. Journal of Drug Delivery Science and Technology 2023; 87: 104810.
• Kolawole O. M., Cook M. In situ gelling drug delivery systems for topical drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2023; 184: 36-49.
• Kolawole O. M., Lau W. M., Khutoryanskiy V. V. Synthesis and Evaluation of Boronated Chitosan as a mucoadhesive polymer for Intravesical Drug Delivery. Journal of Pharmaceutical Sciences 2019; 108:3046-3053
• Kolawole O. M., Lau W. M., Khutoryanskiy V. V. Chitosan/beta-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of Mitomycin C. International Journal of Pharmaceutics X 2019; 1: 100007
• Kolawole O. M., Lau W. M., Khutoryanskiy V. V. Methacrylated chitosan as a polymer with enhanced mucoadhesive properties for transmucosal drug delivery. International Journal of Pharmaceutics 2018; 550; 123-129
• Kolawole O. M., Lau W. M., Mostafid H., Khutoryanskiy V. V. Advances in intravesical drug delivery systems to treat bladder cancer (A Review). International Journal of Pharmaceutics 2017; 532: 105-117.

Full list of Publications

1. Kolawole O. M., Okeke P. K. Formulation and evaluation of fluconazole containing boronated 4 arm polyethylene glycol, polyvinyl pyrrolidone, methyl cellulose-based films for the potential treatment of Vaginal Candidiasis. Journal of Drug Delivery Science and Technology 2025; 107: 106838.
2. Kolawole O. M., Khutoryanskiy V. V. Potential bladder cancer therapeutic delivery systems: a recent update. Expert Opinion on Drug Delivery 2024 volume 21 issue 9, 1311-1329
3. Kolawole O. M., Abu Ellela M. Recent Advances in modified chitosan-based drug delivery systems for transmucosal applications. Int J Biol Macromolecules 2024 volume 227, part 4 page 134531
4. Kolawole O. M., Adesegun A., Isreal S. C. Ayorinde R. Comparative Evaluation of the Physicochemical, Antimicrobial and Stability Profiles of Olive oil, Almond oil, and Coconut oil- based Emulgels. Tropical Journal of Phytochemistry and Pharmaceutical Sciences 2024; 3(1): 92-99
5. Emediegwu C, Oseni B, Ologunagba M, Kolawole O. M., Ologunagba M. O, Azubuike C. P. Nanocellulose crystals reinforced Chitosan hydrogel loaded with artemether- lumefantrine to achieve a sustained release formulation. Tropical Journal of Phytochemistry and Pharmaceutical Sciences 2024. Volume 3 issue 3 page 240-245
6. Ogedengbe O. T., Kolawole O. M. Formulation and evaluation of fluconazole emulgels for potential treatment of vaginal candidiasis. Heliyon 2024; 10: e28206
7. Kolawole O. M. Agbelusi T., Patrojanasophon P. Synthesis and Evaluation of Boronated 4 arm polyethylene glycol for Application in Transmucosal Drug Delivery. Chemistry Select 2024; 9: e202304781 (1-10)
8. Kolawole O. M., Ifeanafor A. R. Ifade W., Akinleye M., Silva B. O., Akinniyi A. Formulation and evaluation of paclitaxel loaded boronated chitosan alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery. Journal of Drug Delivery Science and Technology 2023; 184: 36-49
9. Kolawole O. M., Cook M. In situ gelling drug delivery systems for topical drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2023; 184: 36-49
10. Charles-Okhe O., Kolawole O. M., Silva B. O. Comparative qualitative and quantitative assessment of selected brands of cotrimoxazole tablets and suspensions procured from Lagos State, Nigeria. World Journal of Biology, Pharmacy and Health Sciences 2022; 10(1): 103-114
11. Kolawole O. M. Akinlabi K., Silva B. O. Physicochemical and Stability Profile of castor oil emulsions stabilised using natural and synthetic emulsifiers. World Journal of Biology, Pharmacy and Health Sciences 2022; 9(2): 60-73
12. Ologunagba M. O. Kolawole O. M., Echerenwa A., Silva B. O. Development and characterisation of capsaicin creams formulated with Grewia mucilage-HPMC base. Journal of Science and Practice of Pharmacy 2020; 7(1): 365-375
13. Ologunagba M. O. Kolawole O. M., Echerenwa A., Silva B. O. A Cost-Effective Extraction Method for Improved Physicochemical, Rheological and Microbiological Properties of Grewia mollis gum. Trop J Nat Prod Res 2020; 4(8): 440-445.
14. Kolawole O. M., Lau W. M., Khutoryanskiy V. V. Synthesis and Evaluation of Boronated Chitosan as a mucoadhesive polymer for Intravesical Drug Delivery. Journal of Pharmaceutical Sciences 2019; 108:3046-3053
15. Kolawole O. M., Lau W. M., Khutoryanskiy V. V. Chitosan/beta-glycerophosphate in situ gelling mucoadhesive systems for intravesical delivery of Mitomycin C. International Journal of Pharmaceutics X 2019; 1: 100007
16. Kolawole O. M., Lau W. M., Khutoryanskiy V. V. Methacrylated chitosan as a polymer with enhanced mucoadhesive properties for transmucosal drug delivery. International Journal of Pharmaceutics 2018; 550; 123-129
17. Kolawole O. M., Lau W. M., Mostafid H., Khutoryanskiy V. V. Advances in intravesical drug delivery systems to treat bladder cancer (A Review). International Journal of Pharmaceutics 2017; 532: 105-117
18. Kolawole O. M., Lau W. M., Mostafid H., Khutoryanskiy V. V. Intravesical Drug Delivery for treatment of bladder Cancer. United Kingdom and Ireland Controlled Release Society 2017; page 29-33. Available at UKICRS2016.indd

Key research outputs

1. Formulation of fluconazole containing boronated 4-arm polyethylene glycol, polyvinyl pyrrolidone, methyl cellulose-based vaginal films for potential treatment of vaginal candidiasis, Kolawole & Okeke, Journal of Drug Delivery Science and Technology 107, 106838 (2025)
2. Formulation of Olive oil, almond oil, and coconut oil-based emulgels for potential treatment of skin infections, Kolawole et al., Tropical Journal of Phytochemistry and Pharmaceutical Sciences 3(1), 92-99 (2024)
3. Formulation of Fluconazole emulgels for potential treatment of vaginal candidiasis, Ogedengbe & Kolawole, Heliyon 10, e28206 (2024).
4. Synthesis of Boronated 4-arm polyethylene glycol for bladder drug delivery, Kolawole et al., Chemistry Select 9, e202304781 (1-10) (2024).
5. Formulation of paclitaxel loaded boronated chitosan alginate nanoparticles for potential treatment of cervical cancer, Kolawole et al., Journal of Drug Delivery Science and Technology 184, 36-49 (2023).
6. Formulation of castor oil emulsions for potential topical application, Kolawole et al., Journal of Biology, Pharmacy and Health Sciences 9(2), 60-73 (2022).
7. Synthesis of boronated chitosan for bladder drug delivery, Kolawole et al., Journal of Pharmaceutical Sciences 108, 3046-3053 (2019).
8. Formulation of mitomycin containing chitosan/beta-glycerophosphate in situ gels for potential treatment of bladder cancer. Kolawole et al., International Journal of Pharmaceutics X 1, 100007 (2019).
9. Synthesis of methacrylated chitosan for bladder drug delivery, Kolawole et al. International Journal of Pharmaceutics 550, 123-129 (2018).

• Pharmaceutics/ Pharmaceutical Technologies
• Pharmaceutical Dosage Design
• Biomaterials – biocompatible polymers
• Polymer Science and Chemistry; Physical Chemistry
• Targeted Drug Delivery Systems – dermal, transdermal, transmucosal
• Emulsified Systems
• Stimuli-responsive drug formulations - hydrogels
• Nanoparticles and Microparticles
• Film Formulations
• Drug release and skin/mucosal irritant studies – in vitro, ex vivo and in vivo models
• Molecular Biology: Mammalian culture studies, cytotoxicity testing using MTT assay
• Material Analysis – UV, FT-IR, DSC, XRD, SEM, TEM, Rheology, HPLC, Fluorescence Microscopy, Texture analyser

Core Principles in Pharmaceutical Sciences (Yr 1); Module leadership
Compounding Labs (Yr 1)

University of Reading, UK, Doctor of Philosophy (PhD), Pharmacy
School of Pharmacy, University of London, UK, Master of Science (MSc.), Drug Delivery (Distinction)
Obafemi Awolowo University, Nigeria, Bachelor of Pharmacy (BPharm)

BSc. Pharmaceutical and Cosmetic Sciences

• May 2024 – Drug Carriers in Medicine and Biology, Gordon Research Conference, Portland, Maine, USA, conference registration and accommodation awards ($1320)
• August 2018 – Royal Society of Chemistry Career Development Department Travel Grant to attend European Chemistry Congress, Liverpool, United Kingdom (£600)
• February 2018 – Graduate School/Department of Pharmacy, University of Reading Travel Grant to attend European Chemistry Congress, Liverpool, United Kingdom (£400)
• January 2018 - The Leche Trust Award to support PhD studies (£1,000)
• April 2018 – Gilchrist Educational Grant to support PhD studies (£ 750)
• January 2017 – Department of Pharmacy, University of Reading Research fees waiver (£7, 500).
• October 2010 - Award for Best Performing Student in Master of Science in Drug Delivery program (2009/2010), University College London School of Pharmacy, London, United Kingdom plus cash prize of £500.

• January 2016-January 2019 - Associate Member, Royal Society of Chemistry
• January 2019 to Present - Member, Royal Society of Chemistry
• October 2015 to present - United Kingdom & Ireland Controlled Release Society

4th to 8th August 2024 - Drug Carriers in Medicine and Biology, Gordon Research Conference, Portland, Maine, USA

• Formulation and evaluation of fluconazole containing boronated 4 arm polyethylene glycol, polyvinyl pyrrolidone, methyl cellulose-based films for the potential treatment of Vaginal Candidiasis; Royal Society of Chemistry, Grant Number R23-4644122030, £5,000; research project, start date: October 2023, end date: October 2024; Principal Investigator
• Synthesis and Evaluation of Boronated 4 arm polyethylene glycol for Application in Transmucosal Drug Delivery; Royal Society of Chemistry, Grant Number R21-9528830286, £4,000; research project, start date: May 2022, end date: May 2023; Principal Investigator
• Formulation and evaluation of paclitaxel loaded boronated chitosan alginate nanoparticles as a mucoadhesive system for localized cervical cancer drug delivery; Building Research and Innovation in Nigeria’s Science NIH subgrant; Grant number D43TW010134 (N4, 918,400 = $10,000); ; research project, start date: December 2021, end date: December 2022; Principal Investigator

0000-0003-3200-923X